Baseline Thrombocytopenia and Disease Severity Among COVID-19 Patients, Tibebe Ghion Specialized Hospital COVID-19 Treatment Center, Northwest Ethiopia

References

• UNICEF. Improving Child Nutrition: The Achievable Imperative for Global Progress. New York: UNICEF; 2013:1–14.
   Google Scholar
• Wang L, Wang Y, Ye D, Liu Q. Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence. Int J Antimicrob Agents. 2020;55(6):879. doi:10.1016/j.ijantimicag.2020.105948
   Web of Science ®Google Scholar
• King AM, Lefkowitz EJ, Mushegian AR, et al. Changes to taxonomy and the International Code of Virus Classification and Nomenclature ratified by the International Committee on Taxonomy of Viruses (2018). Arch Virol. 2018;163(9):2601–2631. doi:10.1007/s00705-018-3847-1
   PubMed Web of Science ®Google Scholar
• Rodak BF, Keohane EM, Fritsma GA. Hematology-E-Book: Clinical Principles and Applications. Elsevier Health Sciences; 2013.
   Google Scholar
• Friedrich MS, Studt J-D, Braun J, Spahn DR, Kaserer A. Coronavirus-induced coagulopathy during the course of disease. PLoS One. 2020;15(12):e0243409. doi:10.1371/journal.pone.0243409
   PubMed Web of Science ®Google Scholar
• Mezgebe M, Jacobson BF, Mayne ES, Louw S. Change in platelet indices in patients with Coronavirus disease‐2019 (COVID‐19): a reflection of platelet activation and contribution to immunothrombosis? Int J Lab Hematol. 2022;44(1):e46–e8. doi:10.1111/ijlh.13705
   PubMed Web of Science ®Google Scholar
• Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. doi:10.1016/S0140-6736(20)30211-7
   PubMed Web of Science ®Google Scholar
• Cao W, Li T. COVID-19: towards understanding of pathogenesis. Cell Res. 2020;30(5):367–369. doi:10.1038/s41422-020-0327-4
   PubMed Web of Science ®Google Scholar
• Getu S, Tegenaw Tiruneh HA, Hailemichael W, Kiros T, Belay DM, Kiros M. Coagulopathy in SARS-CoV-2 infected patients: implication for the management of COVID-19. J Blood Med. 2021;12:635. doi:10.2147/JBM.S304783
   PubMed Web of Science ®Google Scholar
• Xu P, Zhou Q, Xu J. Mechanism of thrombocytopenia in COVID-19 patients. Ann Hematol. 2020;99(6):1205–1208. doi:10.1007/s00277-020-04019-0
   PubMed Web of Science ®Google Scholar
• Elshazli RM, Toraih EA, Elgaml A, et al. Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: a meta-analysis of 6320 patients. PLoS One. 2020;15(8):1–20. doi:10.1371/journal.pone.0238160
   Web of Science ®Google Scholar
• Yousif NG, Altimimi AN, Al-amran FG, et al. Hematological changes among Corona virus-19 patients: a longitudinal study. Sys Rev Pharm. 2020;11(5):862–866.
   Google Scholar
• Henry BM, De Oliveira MHS, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020;58(7):1021–1028. doi:10.1515/cclm-2020-0369
   PubMed Web of Science ®Google Scholar
• Wassihun B, Deribe L, Worede N, Gultie T. Prevalence of disrespect and abuse of women during child birth and associated factors in Bahir Dar town, Ethiopia. Epidemiology and Health. 2018;40:e2018029. doi:10.4178/epih.e2018029
   PubMed Web of Science ®Google Scholar
• Israel GD. Determining Sample Size. Israel GD; 1992.
   Google Scholar
• Liu H, Wang Z, Sun H, et al. Thrombosis and coagulopathy in COVID-19: current understanding and implications for antithrombotic treatment in patients treated with percutaneous coronary intervention. Front Cardiovascular Med. 2021;2:378.
   Google Scholar
• Control CfD, Prevention. Alcohol use and your health. Available from: https://wwwcdcgov/alcohol/pdfs/alcoholyourhealthpdf. Accessed February 8, 2014.
   Google Scholar
• Bidira K, Tamiru D, Belachew T. Anthropometric failures and its associated factors among preschool-aged children in a rural community in southwest Ethiopia. PLoS One. 2021;16(11):e0260368. doi:10.1371/journal.pone.0260368
   PubMed Web of Science ®Google Scholar
• National Health Commission of the People’s Republic of China. Chinese Management Guideline for COVID-19 (Version 6.0). National Health Commission of the People’s Republic of China; 2014.
   Google Scholar
• Addis Ababa University. T. A. Performance Evaluation of Cell-Dyn 1800 and Sysmex KX-21 Hematology Analyzers at ST. Paul’s Hospital Millennium Medical College. Addis Ababa, Ethiopia: Addis Ababa University; 2015.
   Google Scholar
• Wool GD, Miller JL. The impact of COVID-19 disease on platelets and coagulation. Pathobiology. 2021;88(1):15–27. doi:10.1159/000512007
   PubMed Web of Science ®Google Scholar
• Lee SG, Fralick M, Sholzberg M. Coagulopathy associated with COVID-19. Canadian Med Assoc J. 2020;192(21):E583. doi:10.1503/cmaj.200685
   Web of Science ®Google Scholar
• Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382(18):1708–1720. doi:10.1056/NEJMoa2002032
   PubMed Web of Science ®Google Scholar
• Delshad M, Safaroghli-Azar A, Pourbagheri-Sigaroodi A, Poopak B, Shokouhi S, Bashash D. Platelets in the perspective of COVID-19; pathophysiology of thrombocytopenia and its implication as prognostic and therapeutic opportunity. Int Immunopharmacol. 2021;99:107995. doi:10.1016/j.intimp.2021.107995
   PubMed Web of Science ®Google Scholar
• Daniels SA, Wei H, Denning DW. Platelet size as a predictor for severity and mortality in COVID-19 patients: a systematic review and meta-analysis. medRxiv. 2021.
   Google Scholar
• Barrett TJ, Bilaloglu S, Cornwell M, et al. Platelets contribute to disease severity in COVID‐19. J Thrombosis Haemostasis. 2021;19(12):3139–3153. doi:10.1111/jth.15534
   PubMed Web of Science ®Google Scholar
• Yatim N, Boussier J, Chocron R, et al. Platelet activation in critically ill COVID-19 patients. Ann Intensive Care. 2021;11(1):1–12. doi:10.1186/s13613-021-00899-1
   PubMed Web of Science ®Google Scholar
• Rampotas A, Pavord S. Platelet aggregates, a marker of severe COVID-19 disease. J Clin Pathol. 2021;74(11):750–751. doi:10.1136/jclinpath-2020-206933
   PubMed Web of Science ®Google Scholar
• Nigam JS, Kumar A, Sinha R, et al. Association of Peripheral Blood Parameters With Outcomes of COVID-19 Infection in a Tertiary Care Setting of Eastern India: an Institute-Based Study. Cureus. 2021;13:12.
   Web of Science ®Google Scholar
• Delshad M, Safaroghli-Azar A, Pourbagheri-Sigaroodi A, Poopak B, Shokouhi S, Bashash D. Platelets in the perspective of COVID-19; pathophysiology of thrombocytopenia and its implication as prognostic and therapeutic opportunity. Int Immunopharmacol. 2021;99:107995.
   PubMed Web of Science ®Google Scholar
• Güçlü E, Kocayiğit H, Okan HD, et al. Effect of COVID-19 on platelet count and its indices. Revista da Associação Médica Brasileira. 2020;66:1122–1127. doi:10.1590/1806-9282.66.8.1122
   PubMed Web of Science ®Google Scholar
• Liu Y, Sun W, Guo Y, et al. Association between platelet parameters and mortality in coronavirus disease 2019: retrospective cohort study. Platelets. 2020;31(4):490–496. doi:10.1080/09537104.2020.1754383
   PubMed Web of Science ®Google Scholar
• Sayad B, Rahimi Z. Blood coagulation parameters in patients with severe COVID-19 from Kermanshah Province, Islamic Republic of Iran. Eastern Mediterranean Health J. 2020;26(9):999–1004. doi:10.26719/emhj.20.105
   PubMed Web of Science ®Google Scholar
• Bikdeli B, Madhavan MV, Jimenez D, et al. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75(23):2950–2973. doi:10.1016/j.jacc.2020.04.031
   PubMed Web of Science ®Google Scholar
• Zanza C, Racca F, Longhitano Y, et al. Risk management and treatment of coagulation disorders related to COVID-19 infection. Int J Environ Res Public Health. 2021;18(3):1268. doi:10.3390/ijerph18031268
   PubMed Web of Science ®Google Scholar
• Lodigiani C, Iapichino G, Carenzo L, et al. Venous and arterial thromboembolic complications in COVID-19 patients admitted to an academic hospital in Milan, Italy. Thromb Res. 2020;191:9–14. doi:10.1016/j.thromres.2020.04.024
   PubMed Web of Science ®Google Scholar
• Cui S, Chen S, Li X, Liu S, Wang F. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia. J Thrombosis Haemostasis. 2020;18(6):1421–1424. doi:10.1111/jth.14830
   PubMed Web of Science ®Google Scholar
• Helms J, Tacquard C, Severac F, et al. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020;46(6):1089–1098. doi:10.1007/s00134-020-06062-x
   PubMed Web of Science ®Google Scholar
• Jin X, Duan Y, Bao T, et al. The values of coagulation function in COVID-19 patients. PLoS One. 2020;15(10):e0241329. doi:10.1371/journal.pone.0241329
   PubMed Web of Science ®Google Scholar
• Lippi G, Plebani M, Henry BM. Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: a meta-analysis. Clinica chimica acta. 2020;506:145–148. doi:10.1016/j.cca.2020.03.022
   PubMed Web of Science ®Google Scholar
• Hana C, Aboulenain S, Dewaswala N, Narendran V. Does Thrombocytopenia Truly Correlate with COVID-19 Severity? Blood. 2020;136:39–40. doi:10.1182/blood-2020-142440
   Web of Science ®Google Scholar
• Bao C, Tao X, Cui W, et al. SARS-CoV-2 induced thrombocytopenia as an important biomarker significantly correlated with abnormal coagulation function, increased intravascular blood clot risk and mortality in COVID-19 patients. Exp Hematol Oncol. 2020;9(1):1–8. doi:10.1186/s40164-020-00172-4
   PubMed Web of Science ®Google Scholar
• Bhandary C, Agarkar P, Manivannan P, Kar R, Basu D. Hematological parameters in covid-19 illness: emphasis on platelet indices as a marker of severity of disease. Indian J Hematol Blood Transfusion. 2020;1:S128.
   Google Scholar
• Aydınyılmaz F, Aksakal E, Pamukcu HE, et al. Significance of MPV, RDW and PDW with the Severity and Mortality of COVID-19 and Effects of Acetylsalicylic Acid Use. Clin Applied Thrombosis Hemostasis. 2021;27:10760296211048808. doi:10.1177/10760296211048808
   Web of Science ®Google Scholar
• Tire Y, Yazar MA, Erdem SS. Can changes in platelet count, mean platelet volume, and platelet distribution width be used to determine the severity of COVID-19? Med Sci Discovery. 2021;8(10):581–585. doi:10.36472/msd.v8i10.611
   Google Scholar
• Yardımcı AC, Yıldız S, Ergen E, et al. Association between platelet indices and the severity of the disease and mortality in patients with COVID-19. Eur Rev Med Pharmacol Sci. 2021;25(21):6731–6740. doi:10.26355/eurrev_202111_27118
   PubMed Web of Science ®Google Scholar
• Chaudhary N, Raju K, Kamarthi P. Profile of Platelet Parameters in Coronavirus Disease–Positive Cases—An Observational Study. Biomed Res Therapy. 2021;8(10):4649–4654. doi:10.15419/bmrat.v8i10.700
   Web of Science ®Google Scholar